医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

TDP-43-immunity-microbiota axis in amyotrophic lateral sclerosis:A potential pathogenic mechanism

摘要Amyotrophic lateral sclerosis is a devastating neurodegenerative disease marked by progressive motor neuron degeneration.Despite extensive research,effective treatments remain elusive,underscoring the need to explore the molecular mechanisms driving disease progression.The amyotrophic lateral sclerosis complexity is further compounded by its large heterogeneity,encompassing both genetic and sporadic forms,diverse phenotypic presentations,and highly variable progression rates.A key pathological feature of amyotrophic lateral sclerosis is the aggregation of TAR DNA-binding protein 43,which contributes to cellular toxicity,neuroinflammation,and neuronal dysfunction.This review explores the complex interplay between TAR DNA-binding protein 43 pathology,immunity dysregulation,and the gut-brain axis,with a focus on the role of microbiome-derived metabolites in amyotrophic lateral sclerosis.Neuroinflammation,mediated by both innate and adaptive immunity,plays a central role in disease pathogenesis,with TAR DNA-binding protein 43 influencing immune signaling and exacerbating neurotoxicity.Additionally,disruptions in gut microbiota composition and intestinal barrier integrity,frequently observed in amyotrophic lateral sclerosis patients,suggest a potential role for the gut-brain axis in modulating neurodegenerative processes.By integrating evidence from emerging studies,our aim is to clarify how TAR DNA-binding protein 43 aggregation contributes to neuroinflammation and immune dysfunction while exploring the gut microbiota role as both a modulator and potential biomarker of disease.Understanding these interactions could pave the way for novel therapeutic strategies,including microbiome-targeted interventions such as probiotics,dietary modifications,or immune-modulating therapies.Finally,unraveling the TAR DNA-binding protein 43-immune system-microbiome axis may offer new avenues for personalized treatments aimed at mitigating neuroinflammation,slowing amyotrophic lateral sclerosis progression,and improving patient outcomes and life quality.

更多
广告
作者 Yasmine Abbassi [1] Dorian Fink [1] Francesco Cei [1] Elena Niccolai [2] Amedeo Amedei [3] 学术成果认领
作者单位 Department of Experimental and Clinical Medicine,University of Florence,Florence,Italy [1] Department of Experimental and Clinical Medicine,University of Florence,Florence,Italy;Laboratorio Congiunto MIA-LAB(Microbiome-Immunity Axis Research for a Circular Health),University of Florence,Florence,Italy [2] Department of Experimental and Clinical Medicine,University of Florence,Florence,Italy;Laboratorio Congiunto MIA-LAB(Microbiome-Immunity Axis Research for a Circular Health),University of Florence,Florence,Italy;Network of Immunity in Infection,Malignancy and Autoimmunity(NIIMA),Universal Scientific Education and Research Network(USERN),Florence,Italy [3]
栏目名称
DOI 10.4103/NRR.NRR-D-25-00440
发布时间 2026-05-20(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载0
中国神经再生研究(英文版)

中国神经再生研究(英文版)

2026年21卷8期

3439-3448页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷